Previous Article | Next Article ![]()
Journal of Bacteriology, January 1999, p. 305-318, Vol. 181, No. 1
School of Pharmacy1
and
Department of Bacteriology,3
University of Wisconsin, Madison, Wisconsin 53706, and
Global Supply/CFO/API, Pharmacia and Upjohn, 20014 Nerviano, Milan, Italy2
Received 27 July 1998/Accepted 29 September 1998
Doxorubicin-overproducing strains of Streptomyces
peucetius ATCC 29050 can be obtained through manipulation of the
genes in the region of the doxorubicin (DXR) gene cluster that contains dpsH, the dpsG polyketide synthase gene, the
putative dnrU ketoreductase gene, dnrV, and the
doxA cytochrome P-450 gene. These five genes were
characterized by sequence analysis, and the effects of replacing dnrU, dnrV, doxA, or
dpsH with mutant alleles and of doxA
overexpression on the production of the principal anthracycline
metabolites of S. peucetius were studied. The exact
roles of dpsH and dnrV could not be
established, although dnrV is implicated in the enzymatic reactions catalyzed by DoxA, but dnrU appears to encode a
ketoreductase specific for the C-13 carbonyl of daunorubicin (DNR) and
DXR or their biosynthetic precursors. The highest DXR titers were
obtained in a dnrX dnrU (N. Lomovskaya, Y. Doi-Katayama,
S. Filippini, C. Nastro, L. Fonstein, M. Gallo, A. L. Colombo, and C. R. Hutchinson, J. Bacteriol. 180:2379-2386, 1998)
double mutant and a dnrX dnrU dnrH (C. Scotti and
C. R. Hutchinson, J. Bacteriol. 178:7316-7321, 1996) triple
mutant. Overexpression of doxA in a
doxA::aphII mutant resulted in the accumulation
of DXR precursors instead of in a notable increase in DXR production.
In contrast, overexpression of dnrV and doxA
jointly in the dnrX dnrU double mutant or the dnrX
dnrU dnrH triple mutant increased the DXR titer 36 to 86%.
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Doxorubicin Overproduction in Streptomyces peucetius:
Cloning and Characterization of the dnrU Ketoreductase and
dnrV Genes and the doxA Cytochrome
P-450 Hydroxylase Gene

*
Corresponding author. Mailing address: School of
Pharmacy, University of Wisconsin, 425 N. Charter St., Madison, WI
53706. Phone: (608) 262-7582. Fax: (608) 262-3134. E-mail:
crhutchi{at}facstaff.wisc.edu.
Present address: Sankyo Co., Ltd., Shinagawa-ku, Tokyo 140, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»